Overview
Status
Active
Registry date
2022-10-05
Share capital
6,000.00 PLN
Registered address
ul. Legnicka 55/Ua5, 54-203 Wrocław, Poland
Electronic delivery address
AE:PL-75408-54276-SSCAC-25
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
2 of 3 financial statements were filed late (the longest delay 568 days for 2023).
- 202518/02/2026
- 202418/02/2026
- 202303/02/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Robert Matelski – President of the Management Board
Manner of representation
In the event of a multi-member management board, two members of the management board jointly or one member of the management board jointly with a commercial proxy are authorized to make declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Joanna Marta Dziokage 43 | 30 | $810.37 | 50% |
Robert Matelskiage 56 | 30 | $810.37 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Wrocławskie Zakłady Zielarskie HerbapolS.A. | $46,537,868.51 | herbapol.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Zeptor Polskasp. z o.o. | $748,374.79 | zeptor.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com |
FAQ
The main business activity of Brandpharmacy focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on October 5, 2022.
The headquarters is located at: ul. Legnicka 55, 54-203 Wrocław.
The share capital of the company is PLN 6,000 (approx. $1,621).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-10-07